AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Prime Medicine, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Dimensional Fund Advisors LP (DFA) has filed a Schedule 13G indicating that, as of 30 June 2025, it beneficially owns 1,572,330 shares of Boston Omaha Corp ("BOC"), representing 5.1 % of the company’s outstanding common stock. The institutional investor reports sole voting power over 1,540,879 shares and sole dispositive power over the full 1,572,330-share position, with no shared voting or dispositive authority.

DFA, a Delaware limited partnership and SEC-registered investment adviser, explains that the shares are held across multiple mutual funds, commingled trusts and separate accounts for which it or its subsidiaries act as adviser or sub-adviser. While DFA may exercise voting and investment discretion, it expressly disclaims beneficial ownership in excess of the requirements of Section 13(d).

Crossing the 5 % ownership threshold triggers this disclosure and signals a modest increase in institutional ownership in BOC. Because DFA is predominantly a passive, quantitative manager, the filing does not suggest an activist agenda or an intention to influence control. Nevertheless, additional institutional sponsorship can enhance liquidity, broaden research coverage and potentially support the share price through index-related demand.

Key numeric details

  • Date of event: 30 June 2025
  • Shares owned: 1,572,330
  • Percent of class: 5.1 %
  • Sole voting power: 1,540,879
  • Sole dispositive power: 1,572,330

Overall, the Schedule 13G is an informative but routine ownership disclosure that underscores growing passive interest in Boston Omaha without materially altering corporate governance or near-term strategy.

Dimensional Fund Advisors LP (DFA) ha presentato un modulo Schedule 13G, segnalando che al 30 giugno 2025 possiede in modo beneficiario 1.572.330 azioni di Boston Omaha Corp ("BOC"), pari al 5,1% del capitale sociale ordinario della società. L'investitore istituzionale dichiara di avere il potere di voto esclusivo su 1.540.879 azioni e il potere dispositive esclusivo sull'intera posizione di 1.572.330 azioni, senza alcuna autorità condivisa di voto o disposizione.

DFA, una società in accomandita del Delaware e consulente d'investimento registrato presso la SEC, spiega che le azioni sono detenute tramite molteplici fondi comuni, trust commisti e conti separati per i quali DFA o le sue controllate agiscono come consulenti o sub-consulenti. Pur potendo esercitare discrezionalmente il voto e gli investimenti, DFA dichiara espressamente di non rivendicare la proprietà beneficiaria oltre i requisiti della Sezione 13(d).

Il superamento della soglia del 5% di proprietà richiede questa comunicazione e indica un modesto aumento della partecipazione istituzionale in BOC. Poiché DFA è principalmente un gestore passivo e quantitativo, la segnalazione non suggerisce un'agenda attivista o l'intenzione di influenzare il controllo. Tuttavia, una maggiore sponsorizzazione istituzionale può migliorare la liquidità, ampliare la copertura degli analisti e potenzialmente sostenere il prezzo delle azioni grazie alla domanda legata agli indici.

Dettagli numerici principali

  • Data dell'evento: 30 giugno 2025
  • Azioni possedute: 1.572.330
  • Percentuale della classe: 5,1%
  • Potere di voto esclusivo: 1.540.879
  • Potere dispositive esclusivo: 1.572.330

In generale, il modulo Schedule 13G rappresenta una comunicazione informativa ma di routine sulla proprietà, che evidenzia il crescente interesse passivo in Boston Omaha senza modificare sostanzialmente la governance aziendale o la strategia a breve termine.

Dimensional Fund Advisors LP (DFA) ha presentado un Schedule 13G indicando que, al 30 de junio de 2025, posee beneficiariamente 1.572.330 acciones de Boston Omaha Corp ("BOC"), lo que representa el 5,1% del capital social común en circulación de la compañía. El inversor institucional reporta tener el poder de voto exclusivo sobre 1.540.879 acciones y el poder dispositive exclusivo sobre la totalidad de las 1.572.330 acciones, sin autoridad compartida de voto o disposición.

DFA, una sociedad limitada de Delaware y asesor de inversiones registrado en la SEC, explica que las acciones se mantienen en múltiples fondos mutuos, fideicomisos combinados y cuentas separadas para los cuales DFA o sus subsidiarias actúan como asesores o subasesores. Aunque DFA puede ejercer discreción de voto e inversión, declara expresamente que no reclama la propiedad beneficiaria más allá de los requisitos de la Sección 13(d).

Al cruzar el umbral del 5% de propiedad, se activa esta divulgación, señalando un aumento moderado en la propiedad institucional de BOC. Dado que DFA es principalmente un gestor pasivo y cuantitativo, la presentación no sugiere una agenda activista ni intención de influir en el control. Sin embargo, un mayor patrocinio institucional puede mejorar la liquidez, ampliar la cobertura de investigación y potencialmente apoyar el precio de las acciones mediante la demanda relacionada con índices.

Detalles numéricos clave

  • Fecha del evento: 30 de junio de 2025
  • Acciones poseídas: 1.572.330
  • Porcentaje de la clase: 5,1%
  • Poder de voto exclusivo: 1.540.879
  • Poder dispositive exclusivo: 1.572.330

En general, el Schedule 13G es una divulgación informativa pero rutinaria sobre la propiedad que subraya el creciente interés pasivo en Boston Omaha sin alterar materialmente la gobernanza corporativa o la estrategia a corto plazo.

Dimensional Fund Advisors LP (DFA)ëŠ� 2025ë…� 6ì›� 30ì� 기준으로 Boston Omaha Corp("BOC")ì� 1,572,330ì£�ë¥� 실질ì ìœ¼ë¡� 보유하고 있ìŒì� 나타내는 Schedule 13Gë¥� 제출했습니다. ì´ëŠ” 회사ì� 보통ì£� 발행 주ì‹ì� 5.1%ì—� 해당합니ë‹�. 기관 투ìžìžëŠ” 1,540,879ì£¼ì— ëŒ€í•� ë‹¨ë… ì˜ê²°ê¶�ê³� ì „ì²´ 1,572,330ì£¼ì— ëŒ€í•� ë‹¨ë… ì²˜ë¶„ê¶�ì� 보유하고 있으ë©�, ê³µë™ ì˜ê²°ê¶Œì´ë‚� ì²˜ë¶„ê¶Œì€ ì—†ë‹¤ê³� 보고했습니다.

DFAëŠ� ë¸ë¼ì›¨ì–´ 유한책임조합ì´ìž SECì—� 등ë¡ë� íˆ¬ìž ìžë¬¸ì‚¬ë¡œ, 해당 주ì‹ë“¤ì€ DFA ë˜ëŠ” ê·� ìžíšŒì‚¬ê°€ ìžë¬¸ ë˜ëŠ” ë¶€ìžë¬¸ ì—­í• ì� 하는 여러 뮤추ì–� 펀ë“�, 혼합 ì‹ íƒ ë°� ë³„ë„ ê³„ì¢Œì—� ë¶„ì‚° 보유ë˜ê³  있다ê³� 설명합니ë‹�. DFAëŠ� ì˜ê²°ê¶� ë°� íˆ¬ìž ìž¬ëŸ‰ì� 행사í•� ìˆ� 있으ë‚�, 명시ì ìœ¼ë¡� 섹션 13(d) 요건ì� 초과하는 실질ì � ì†Œìœ ê¶Œì„ ë¶¶Äì�한다ê³� ë°í˜”습니ë‹�.

5% 소유ê¶� ìž„ê³„ê°’ì„ ë„˜ìŒì—� ë”°ë¼ ì� 공시가 필요해졌으며, ì´ëŠ” BOCì—� 대í•� 기관 소유ê¶�ì� ì†Œí­ ì¦ê°€ë¥� ì˜ë¯¸í•©ë‹ˆë‹�. DFAê°€ 주로 수ë™ì ì´ê³� 정량ì ì¸ 운용사ì´ê¸� 때문ì—�, ì´ë²ˆ ì œì¶œì€ í–‰ë™ì£¼ì˜ì � ì˜ì œë‚� 지배권 ì˜í–¥ ì˜ë„ë¥� 시사하지 않습니다. 그럼ì—ë„ ë¶ˆêµ¬í•˜ê³  추가ì ì¸ 기관 후ì›ì€ 유ë™ì„±ì„ 높ì´ê³�, 리서ì¹� 커버리지ë¥� 확대하며, ì§€ìˆ� ê´€ë � 수요ë¥� 통해 주가ë¥� 지지í•� ìˆ� 있습니다.

주요 수치

  • 사건 ì¼ìž: 2025ë…� 6ì›� 30ì�
  • 보유 ì£¼ì‹ ìˆ�: 1,572,330ì£�
  • 보유 비율: 5.1%
  • ë‹¨ë… ì˜ê²°ê¶�: 1,540,879ì£�
  • ë‹¨ë… ì²˜ë¶„ê¶�: 1,572,330ì£�

ì „ë°˜ì ìœ¼ë¡� Schedule 13GëŠ� Boston Omahaì—� 대í•� 수ë™ì � ê´€ì‹¬ì´ ì¦ê°€í•˜ê³  있ìŒì� 보여주는 ì •ë³´ 제공용ì´ìž� ì¼ìƒì ì¸ 소유ê¶� 공시ë¡�, 기업 지배구조나 단기 ì „ëžµì—� 실질ì ì¸ 변화를 주지ëŠ� 않습니다.

Dimensional Fund Advisors LP (DFA) a déposé un Schedule 13G indiquant qu’au 30 juin 2025, il détient en propriété bénéficiaire 1 572 330 actions de Boston Omaha Corp (« BOC »), représentant 5,1 % du capital social ordinaire en circulation de la société. L’investisseur institutionnel déclare détenir le pouvoir de vote exclusif sur 1 540 879 actions et le pouvoir de disposition exclusif sur la totalité des 1 572 330 actions, sans autorité de vote ou de disposition partagée.

DFA, une société en commandite du Delaware et conseiller en investissement enregistré auprès de la SEC, explique que les actions sont détenues dans plusieurs fonds communs de placement, trusts comminglés et comptes séparés pour lesquels DFA ou ses filiales agissent en tant que conseiller ou sous-conseiller. Bien que DFA puisse exercer une discrétion de vote et d’investissement, il décline expressément la propriété bénéficiaire au-delà des exigences de la Section 13(d).

Le franchissement du seuil de détention de 5 % déclenche cette déclaration et signale une légère augmentation de la détention institutionnelle dans BOC. Étant donné que DFA est principalement un gestionnaire passif et quantitatif, ce dépôt ne suggère pas une stratégie activiste ni une intention d’influencer le contrôle. Néanmoins, un soutien institutionnel accru peut améliorer la liquidité, élargir la couverture des analystes et potentiellement soutenir le cours de l’action par la demande liée aux indices.

Détails clés

  • Date de l’événement : 30 juin 2025
  • Actions détenues : 1 572 330
  • Pourcentage de la classe : 5,1 %
  • Pouvoir de vote exclusif : 1 540 879
  • Pouvoir de disposition exclusif : 1 572 330

Dans l’ensemble, le Schedule 13G est une déclaration informative mais routinière de propriété qui souligne l’intérêt passif croissant pour Boston Omaha sans modifier sensiblement la gouvernance d’entreprise ni la stratégie à court terme.

Dimensional Fund Advisors LP (DFA) hat einen Schedule 13G eingereicht, der angibt, dass es zum 30. Juni 2025 wirtschaftlich 1.572.330 Aktien der Boston Omaha Corp („BOC�) besitzt, was 5,1% des ausstehenden Stammkapitals des Unternehmens entspricht. Der institutionelle Investor berichtet über alleinige Stimmrechte für 1.540.879 Aktien und alleinige Verfügungsgewalt über die gesamte Position von 1.572.330 Aktien, ohne geteilte Stimm- oder Verfügungsrechte.

DFA, eine Limited Partnership aus Delaware und bei der SEC registrierter Investmentberater, erklärt, dass die Aktien über mehrere Investmentfonds, gemischte Treuhandkonten und separate Konten gehalten werden, für die DFA oder seine Tochtergesellschaften als Berater oder Subberater fungieren. Obwohl DFA Stimm- und Investitionsdisposition ausüben kann, verzichtet es ausdrücklich auf das wirtschaftliche Eigentum über die Anforderungen von Abschnitt 13(d) hinaus.

Das Überschreiten der 5-%-Eigentumsschwelle löst diese Meldung aus und signalisiert einen moderaten Anstieg des institutionellen Besitzes an BOC. Da DFA überwiegend ein passiver, quantitativer Manager ist, deutet die Meldung nicht auf eine aktivistische Agenda oder eine Absicht hin, die Kontrolle zu beeinflussen. Dennoch kann zusätzliche institutionelle Unterstützung die Liquidität verbessern, die Research-Abdeckung erweitern und möglicherweise den Aktienkurs durch indexbezogene Nachfrage stützen.

Wichtige Zahlen

  • Datum des Ereignisses: 30. Juni 2025
  • Besessene Aktien: 1.572.330
  • Prozentanteil der Klasse: 5,1%
  • Alleinige Stimmrechte: 1.540.879
  • Alleinige Verfügungsgewalt: 1.572.330

Insgesamt ist der Schedule 13G eine informative, aber routinemäßige Eigentumsmitteilung, die das wachsende passive Interesse an Boston Omaha unterstreicht, ohne die Unternehmensführung oder kurzfristige Strategie wesentlich zu verändern.

Positive
  • Institutional ownership increases to 5.1 %: Dimensional Fund Advisorsâ€� stake broadens BOC’s shareholder base and may improve trading liquidity.
Negative
  • Potential future overhang risk: As a passive manager, DFA could rebalance or exit without strategic considerations, creating sell-side pressure if market conditions dictate.

Insights

TL;DR Passive manager DFA owns 5.1 % of BOC; supports liquidity but unlikely to drive strategic change.

DFA’s 1.57 million-share stake crosses the SEC’s 5 % reporting line. As a quantitative index-oriented adviser, DFA buys for portfolio construction rather than activism. The passive nature limits governance impact, yet higher institutional ownership can narrow bid-ask spreads and reduce volatility. Given Boston Omaha’s market cap around US$700-800 million (not stated in filing, estimate withheld), the position is meaningful but not controlling. I classify the disclosure as moderately positive but not highly impactful for valuation.

TL;DR 5 % threshold reached; no control shift, disclosure mainly improves transparency for investors.

Schedule 13G filings from passive advisers highlight compliance rather than intent to influence. DFA’s disclaimer of beneficial ownership reinforces its non-activist stance. No group formation, subsidiary acquisition or voting agreement is reported. Therefore, board dynamics remain unchanged. The filing’s chief value lies in signalling rising institutional monitoring of BOC, which can enhance governance discipline over time. Impact: neutral to mildly positive.

Dimensional Fund Advisors LP (DFA) ha presentato un modulo Schedule 13G, segnalando che al 30 giugno 2025 possiede in modo beneficiario 1.572.330 azioni di Boston Omaha Corp ("BOC"), pari al 5,1% del capitale sociale ordinario della società. L'investitore istituzionale dichiara di avere il potere di voto esclusivo su 1.540.879 azioni e il potere dispositive esclusivo sull'intera posizione di 1.572.330 azioni, senza alcuna autorità condivisa di voto o disposizione.

DFA, una società in accomandita del Delaware e consulente d'investimento registrato presso la SEC, spiega che le azioni sono detenute tramite molteplici fondi comuni, trust commisti e conti separati per i quali DFA o le sue controllate agiscono come consulenti o sub-consulenti. Pur potendo esercitare discrezionalmente il voto e gli investimenti, DFA dichiara espressamente di non rivendicare la proprietà beneficiaria oltre i requisiti della Sezione 13(d).

Il superamento della soglia del 5% di proprietà richiede questa comunicazione e indica un modesto aumento della partecipazione istituzionale in BOC. Poiché DFA è principalmente un gestore passivo e quantitativo, la segnalazione non suggerisce un'agenda attivista o l'intenzione di influenzare il controllo. Tuttavia, una maggiore sponsorizzazione istituzionale può migliorare la liquidità, ampliare la copertura degli analisti e potenzialmente sostenere il prezzo delle azioni grazie alla domanda legata agli indici.

Dettagli numerici principali

  • Data dell'evento: 30 giugno 2025
  • Azioni possedute: 1.572.330
  • Percentuale della classe: 5,1%
  • Potere di voto esclusivo: 1.540.879
  • Potere dispositive esclusivo: 1.572.330

In generale, il modulo Schedule 13G rappresenta una comunicazione informativa ma di routine sulla proprietà, che evidenzia il crescente interesse passivo in Boston Omaha senza modificare sostanzialmente la governance aziendale o la strategia a breve termine.

Dimensional Fund Advisors LP (DFA) ha presentado un Schedule 13G indicando que, al 30 de junio de 2025, posee beneficiariamente 1.572.330 acciones de Boston Omaha Corp ("BOC"), lo que representa el 5,1% del capital social común en circulación de la compañía. El inversor institucional reporta tener el poder de voto exclusivo sobre 1.540.879 acciones y el poder dispositive exclusivo sobre la totalidad de las 1.572.330 acciones, sin autoridad compartida de voto o disposición.

DFA, una sociedad limitada de Delaware y asesor de inversiones registrado en la SEC, explica que las acciones se mantienen en múltiples fondos mutuos, fideicomisos combinados y cuentas separadas para los cuales DFA o sus subsidiarias actúan como asesores o subasesores. Aunque DFA puede ejercer discreción de voto e inversión, declara expresamente que no reclama la propiedad beneficiaria más allá de los requisitos de la Sección 13(d).

Al cruzar el umbral del 5% de propiedad, se activa esta divulgación, señalando un aumento moderado en la propiedad institucional de BOC. Dado que DFA es principalmente un gestor pasivo y cuantitativo, la presentación no sugiere una agenda activista ni intención de influir en el control. Sin embargo, un mayor patrocinio institucional puede mejorar la liquidez, ampliar la cobertura de investigación y potencialmente apoyar el precio de las acciones mediante la demanda relacionada con índices.

Detalles numéricos clave

  • Fecha del evento: 30 de junio de 2025
  • Acciones poseídas: 1.572.330
  • Porcentaje de la clase: 5,1%
  • Poder de voto exclusivo: 1.540.879
  • Poder dispositive exclusivo: 1.572.330

En general, el Schedule 13G es una divulgación informativa pero rutinaria sobre la propiedad que subraya el creciente interés pasivo en Boston Omaha sin alterar materialmente la gobernanza corporativa o la estrategia a corto plazo.

Dimensional Fund Advisors LP (DFA)ëŠ� 2025ë…� 6ì›� 30ì� 기준으로 Boston Omaha Corp("BOC")ì� 1,572,330ì£�ë¥� 실질ì ìœ¼ë¡� 보유하고 있ìŒì� 나타내는 Schedule 13Gë¥� 제출했습니다. ì´ëŠ” 회사ì� 보통ì£� 발행 주ì‹ì� 5.1%ì—� 해당합니ë‹�. 기관 투ìžìžëŠ” 1,540,879ì£¼ì— ëŒ€í•� ë‹¨ë… ì˜ê²°ê¶�ê³� ì „ì²´ 1,572,330ì£¼ì— ëŒ€í•� ë‹¨ë… ì²˜ë¶„ê¶�ì� 보유하고 있으ë©�, ê³µë™ ì˜ê²°ê¶Œì´ë‚� ì²˜ë¶„ê¶Œì€ ì—†ë‹¤ê³� 보고했습니다.

DFAëŠ� ë¸ë¼ì›¨ì–´ 유한책임조합ì´ìž SECì—� 등ë¡ë� íˆ¬ìž ìžë¬¸ì‚¬ë¡œ, 해당 주ì‹ë“¤ì€ DFA ë˜ëŠ” ê·� ìžíšŒì‚¬ê°€ ìžë¬¸ ë˜ëŠ” ë¶€ìžë¬¸ ì—­í• ì� 하는 여러 뮤추ì–� 펀ë“�, 혼합 ì‹ íƒ ë°� ë³„ë„ ê³„ì¢Œì—� ë¶„ì‚° 보유ë˜ê³  있다ê³� 설명합니ë‹�. DFAëŠ� ì˜ê²°ê¶� ë°� íˆ¬ìž ìž¬ëŸ‰ì� 행사í•� ìˆ� 있으ë‚�, 명시ì ìœ¼ë¡� 섹션 13(d) 요건ì� 초과하는 실질ì � ì†Œìœ ê¶Œì„ ë¶¶Äì�한다ê³� ë°í˜”습니ë‹�.

5% 소유ê¶� ìž„ê³„ê°’ì„ ë„˜ìŒì—� ë”°ë¼ ì� 공시가 필요해졌으며, ì´ëŠ” BOCì—� 대í•� 기관 소유ê¶�ì� ì†Œí­ ì¦ê°€ë¥� ì˜ë¯¸í•©ë‹ˆë‹�. DFAê°€ 주로 수ë™ì ì´ê³� 정량ì ì¸ 운용사ì´ê¸� 때문ì—�, ì´ë²ˆ ì œì¶œì€ í–‰ë™ì£¼ì˜ì � ì˜ì œë‚� 지배권 ì˜í–¥ ì˜ë„ë¥� 시사하지 않습니다. 그럼ì—ë„ ë¶ˆêµ¬í•˜ê³  추가ì ì¸ 기관 후ì›ì€ 유ë™ì„±ì„ 높ì´ê³�, 리서ì¹� 커버리지ë¥� 확대하며, ì§€ìˆ� ê´€ë � 수요ë¥� 통해 주가ë¥� 지지í•� ìˆ� 있습니다.

주요 수치

  • 사건 ì¼ìž: 2025ë…� 6ì›� 30ì�
  • 보유 ì£¼ì‹ ìˆ�: 1,572,330ì£�
  • 보유 비율: 5.1%
  • ë‹¨ë… ì˜ê²°ê¶�: 1,540,879ì£�
  • ë‹¨ë… ì²˜ë¶„ê¶�: 1,572,330ì£�

ì „ë°˜ì ìœ¼ë¡� Schedule 13GëŠ� Boston Omahaì—� 대í•� 수ë™ì � ê´€ì‹¬ì´ ì¦ê°€í•˜ê³  있ìŒì� 보여주는 ì •ë³´ 제공용ì´ìž� ì¼ìƒì ì¸ 소유ê¶� 공시ë¡�, 기업 지배구조나 단기 ì „ëžµì—� 실질ì ì¸ 변화를 주지ëŠ� 않습니다.

Dimensional Fund Advisors LP (DFA) a déposé un Schedule 13G indiquant qu’au 30 juin 2025, il détient en propriété bénéficiaire 1 572 330 actions de Boston Omaha Corp (« BOC »), représentant 5,1 % du capital social ordinaire en circulation de la société. L’investisseur institutionnel déclare détenir le pouvoir de vote exclusif sur 1 540 879 actions et le pouvoir de disposition exclusif sur la totalité des 1 572 330 actions, sans autorité de vote ou de disposition partagée.

DFA, une société en commandite du Delaware et conseiller en investissement enregistré auprès de la SEC, explique que les actions sont détenues dans plusieurs fonds communs de placement, trusts comminglés et comptes séparés pour lesquels DFA ou ses filiales agissent en tant que conseiller ou sous-conseiller. Bien que DFA puisse exercer une discrétion de vote et d’investissement, il décline expressément la propriété bénéficiaire au-delà des exigences de la Section 13(d).

Le franchissement du seuil de détention de 5 % déclenche cette déclaration et signale une légère augmentation de la détention institutionnelle dans BOC. Étant donné que DFA est principalement un gestionnaire passif et quantitatif, ce dépôt ne suggère pas une stratégie activiste ni une intention d’influencer le contrôle. Néanmoins, un soutien institutionnel accru peut améliorer la liquidité, élargir la couverture des analystes et potentiellement soutenir le cours de l’action par la demande liée aux indices.

Détails clés

  • Date de l’événement : 30 juin 2025
  • Actions détenues : 1 572 330
  • Pourcentage de la classe : 5,1 %
  • Pouvoir de vote exclusif : 1 540 879
  • Pouvoir de disposition exclusif : 1 572 330

Dans l’ensemble, le Schedule 13G est une déclaration informative mais routinière de propriété qui souligne l’intérêt passif croissant pour Boston Omaha sans modifier sensiblement la gouvernance d’entreprise ni la stratégie à court terme.

Dimensional Fund Advisors LP (DFA) hat einen Schedule 13G eingereicht, der angibt, dass es zum 30. Juni 2025 wirtschaftlich 1.572.330 Aktien der Boston Omaha Corp („BOC�) besitzt, was 5,1% des ausstehenden Stammkapitals des Unternehmens entspricht. Der institutionelle Investor berichtet über alleinige Stimmrechte für 1.540.879 Aktien und alleinige Verfügungsgewalt über die gesamte Position von 1.572.330 Aktien, ohne geteilte Stimm- oder Verfügungsrechte.

DFA, eine Limited Partnership aus Delaware und bei der SEC registrierter Investmentberater, erklärt, dass die Aktien über mehrere Investmentfonds, gemischte Treuhandkonten und separate Konten gehalten werden, für die DFA oder seine Tochtergesellschaften als Berater oder Subberater fungieren. Obwohl DFA Stimm- und Investitionsdisposition ausüben kann, verzichtet es ausdrücklich auf das wirtschaftliche Eigentum über die Anforderungen von Abschnitt 13(d) hinaus.

Das Überschreiten der 5-%-Eigentumsschwelle löst diese Meldung aus und signalisiert einen moderaten Anstieg des institutionellen Besitzes an BOC. Da DFA überwiegend ein passiver, quantitativer Manager ist, deutet die Meldung nicht auf eine aktivistische Agenda oder eine Absicht hin, die Kontrolle zu beeinflussen. Dennoch kann zusätzliche institutionelle Unterstützung die Liquidität verbessern, die Research-Abdeckung erweitern und möglicherweise den Aktienkurs durch indexbezogene Nachfrage stützen.

Wichtige Zahlen

  • Datum des Ereignisses: 30. Juni 2025
  • Besessene Aktien: 1.572.330
  • Prozentanteil der Klasse: 5,1%
  • Alleinige Stimmrechte: 1.540.879
  • Alleinige Verfügungsgewalt: 1.572.330

Insgesamt ist der Schedule 13G eine informative, aber routinemäßige Eigentumsmitteilung, die das wachsende passive Interesse an Boston Omaha unterstreicht, ohne die Unternehmensführung oder kurzfristige Strategie wesentlich zu verändern.

0001894562false00018945622025-07-142025-07-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

July 14, 2025
Date of Report (date of earliest event reported)
___________________________________
Prime Medicine, Inc.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
(State or other jurisdiction of
incorporation)
001-41536
(Commission File Number)
84-3097762
(I.R.S. Employer Identification No.)
60 First Street
Cambridge, MA 02139
(Address of principal executive offices and zip code)
(617) 465-0013
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $.00001 per sharePRMEThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule12b-2 of the Securities Exchange Act of 1934 (§250.12b-2 of this chapter).
Emerging growth company    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 14, 2025, Prime Medicine, Inc. (the "Company") announced that Jeremy Duffield, M.D. Ph.D., FRCP will step down from his role as Chief Scientific Officer of the Company, effective as of July 15, 2025 (the “Separation”).
In connection with the Separation, the Company intends to enter into a Separation Agreement with Dr. Duffield (the “Separation Agreement”), pursuant to which Dr. Duffield will be entitled to receive severance benefits consistent with the terms of his Amended and Restated Employment Agreement with the Company, dated July 20, 2022. Additionally, following the effective date of the Separation, the Company intends to retain certain consulting and advisory services of Dr. Duffield (the “Consulting Agreement”), effective as of the close of business on July 15, 2025 through March 31, 2026 (the “Advisory Period”). During the Advisory Period, all of Dr. Duffield’s outstanding equity awards will continue to vest in accordance with their terms.
The foregoing summaries of the Separation Agreement and Consulting Agreement do not purport to be complete and are qualified in their entirety by references to the full texts of the Separation Agreement and Consulting Agreement, copies of which the Company intends to file as exhibits to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 15, 2025
Prime Medicine, Inc.
By:
/s/ Allan Reine
Name:
Allan Reine, M.D.
Title:
Chief Executive Officer

FAQ

Why did Dimensional Fund Advisors file a Schedule 13G for Boston Omaha (BOC)?

DFA crossed the 5 % ownership threshold, triggering the SEC’s beneficial-ownership disclosure rule.

How many Boston Omaha shares does Dimensional Fund Advisors own?

The filing states 1,572,330 shares, equal to 5.1 % of outstanding common stock.

Does Dimensional Fund Advisors have voting control over Boston Omaha?

DFA reports sole voting power for 1,540,879 shares and no shared voting authority.

Is Dimensional Fund Advisors pursuing activism at Boston Omaha?

No. The Schedule 13G, rather than a 13D, and explicit disclaimers indicate a passive investment with no intent to influence control.

What is the significance of the 5 % ownership level for investors?

Crossing 5 % requires public disclosure, offering transparency about large holders and often signalling increased institutional attention.

When was the ownership position effective and when was the filing signed?

The relevant event date is 30 June 2025, and the filing was signed on 15 July 2025 by DFA’s Global Chief Compliance Officer.
Prime Medicine

NASDAQ:PRME

PRME Rankings

PRME Latest News

PRME Latest SEC Filings

PRME Stock Data

527.22M
102.56M
23.91%
59.05%
13.76%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
CAMBRIDGE